NCT07371741 PICS Clinic Attendance and Recovery Engagement (PICS-CARE)
| NCT ID | NCT07371741 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Post-intensive Care Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2026-02-10 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To identify relevant factors influencing attendance at appointments at the PICS outpatient clinic after intensive care treatment in order to derive targeted measures to increase the participation rate or send more targeted invitations.
Eligibility Criteria
Inclusion Criteria: * Patients who, between January 1, 2021, and December 31, 2025: * were invited for follow-up care by the PICS outpatient clinic of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) * were ≥18 years old at the time of the appointment. Exclusion Criteria: * none
Contact & Investigator
Claudia Spies, MD, Prof.
STUDY DIRECTOR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT07371741 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post-intensive Care Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07371741 currently recruiting?
Yes, NCT07371741 is actively recruiting participants. Contact the research team at claudia.spies@charite.de for enrollment information.
Where is the NCT07371741 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT07371741 clinical trial?
NCT07371741 is sponsored by Charite University, Berlin, Germany. The principal investigator is Claudia Spies, MD, Prof. at Charite University, Berlin, Germany. The trial plans to enroll 2,500 participants.